Results 251 to 260 of about 3,997,149 (388)

Interaction of antihypertensive drugs with atorvastatin in hyperlipidemic cardiac patients

, 2012
Muhammad Sohail, Khalid Hussain Janbaz, Saeed Ahmad, Tariq Abbas   +3 more
openalex   +1 more source

Spectrophotometric approach for deconvolving overlapped spectra of antihypertensive drug mixtures using UV detection: an eco-friendly method. [PDF]

BMC Chem
Yenduri S, Prashant KN, Varalakshmi HN.
europepmc   +1 more source

SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Randomized controlled trials on sodium‐glucose cotransporter 2 (SGLT2) inhibitors have yielded inconsistent findings regarding mortality benefits. It remains unclear whether, and in which subgroups, SGLT2 inhibitors confer survival benefits in older adults with diabetic kidney disease (DKD).
Tatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, Yuta Suzuki, Toshiyuki Ko, Kazuki Aoyama, Takashin Nakayama, Yuya Kimura, Katsuhiko Fujiu, Norifumi Takeda, Hiroyuki Morita, Takashi Yokoo, Koichi Node, Masaomi Nangaku, Norihiko Takeda, Hideo Yasunaga, Kaori Hayashi   +16 more
wiley   +1 more source

Antihypertensive drug class and adherence: an electronic monitoring study.

American Journal of Hypertension, 2015
Nathalie Moise, J. Schwartz, Rachel Bring, D. Shimbo, I. Kronish   +4 more
semanticscholar   +1 more source

Antihypertensive medication is not associated with increased disease severity in atopic dermatitis in the TREATgermany registry

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Moritz M. Hollstein, Stephan Traidl, Thomas Werfel, Jochen Schmitt, the TREATgermany Study Group   +4 more
wiley   +1 more source

Rationale and design of a parallel randomised trial of a plant‐based intensive lifestyle intervention for diabetes remission: The REmission of diabetes using a PlAnt‐based weight loss InteRvention (REPAIR) trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims As type 2 diabetes (T2D) continues to rise globally and remains a major driver of cardiovascular disease, its remission has emerged as a therapeutic target. Current evidence supports bariatric surgery and low‐calorie diets with meal replacements.
Brighid McKay, Dayana El Chaar, Melanie Paquette, Michael Vallis, Diana Sherifali, Paul Oh, Susan Marzolini, Kaberi Dasgupta, Gillian Booth, Mike Lean, Hertzel C. Gerstein, Jordi Salas‐Salvadó, Jacqueline L. Beaudry, Christopher P. F. Marinangeli, Russell J. de Souza, Lawrence A. Leiter, Cyril W. C. Kendall, David J. A. Jenkins, John L. Sievenpiper, Laura Chiavaroli   +19 more
wiley   +1 more source

A Comparative Study between Antihypertensive Drugs (Methyldopa, Labetalol, and Nifedipine) in Pre-Eclamptic Women: A Randomized Controlled Trial [PDF]

Magdy Selim, Mohamed Elsharawy, Shereef L. Elshwaikh, Ahmed Abou Freikha   +3 more
openalex   +1 more source

Trends in Antihypertensive Drug Use and Irrational Prescriptions Among Elderly Patients in China (2016-2023): A Nationwide Multi-Center Cross-Sectional Survey Study. [PDF]

Drug Des Devel Ther
Hong D, Chen W, Du S, Ren J, Lv D, Shan W, Lu X, Zhao Q.   +7 more
europepmc   +1 more source

Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost‐effectiveness modelling study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Coronary artery calcium (CAC) scoring is observed to improve risk stratification for major adverse cardiovascular events (MACE). Semaglutide, a recently introduced anti‐obesity drug, is very effective, but wider use is limited due to high costs.
Sai Rahul Ponnana, Tong Zhang, Santosh Kumar Sirasapalli, Zhuo Chen, Jean‐Eudes Dazard, Niketh Surya, Shamsa Elhussain, Kanimozhi Sivanantham, Robert Okyere, Ian J. Neeland, Sanjay Rajagopalan, Salil V. Deo   +11 more
wiley   +1 more source

A Review Report on Antihypertensive Drug

Ms. Bushra Malani
openalex   +1 more source